ADJUVANT 5 FU-IRRADIATION-5 FU FOLLOWING MASTECTOMY IN HIGH-RISK PATIENTS

被引：0
|
作者：
RAMIREZ, G
机构：
[1] UNIV WISCONSIN,DIV CLIN ONCOL,MADISON,WI 53706
[2] UNIV WISCONSIN,DIV RADIOTHERAPY,MADISON,WI 53706
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1976年 / 17卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：49 / 49
页数：1
相关论文
共 50 条
  • [41] Cerebral demyelination during adjuvant treatment with fluorouracil (5-FU) and Levamisole
    Galassi, G
    Tassone, G
    Marchi, M
    Sintini, M
    Santini, A
    Mavilia, L
    BRAIN PATHOLOGY, 1997, 7 (04) : 1081 - 1081
  • [42] MTHFR polymorphisms and 5-FU-based adjuvant chemotherapy in colorectal cancer
    Afzal, S.
    Jensen, S. A.
    Vainer, B.
    Vogel, U.
    Matsen, J. P.
    Sorensen, J. B.
    Andersen, P. K.
    Poulsen, H. E.
    ANNALS OF ONCOLOGY, 2009, 20 (10) : 1660 - 1666
  • [43] Optimization of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of leucovorin, 5-FU and cisplatin (LV5FU2-P regimen) in patients with biliary tract carcinoma
    Taïeb, J
    Mitry, E
    Boige, V
    Artru, P
    Ezenfis, J
    Lecomte, T
    Clavero-Fabri, MC
    ANNALS OF ONCOLOGY, 2002, 13 (08) : 1192 - 1196
  • [44] Adjuvant postoperative radiation therapy +/- 5-FU in resected carcinoma of the pancreas
    Foo, ML
    Gunderson, LL
    HEPATO-GASTROENTEROLOGY, 1998, 45 (21) : 613 - 623
  • [45] NO EFFECT OF DOSE, HEPATIC-FUNCTION, OR NUTRITIONAL-STATUS ON 5-FU CLEARANCE FOLLOWING CONTINUOUS (5-DAY), 5-FU INFUSION
    FLEMING, RA
    MILANO, GA
    ETIENNE, MC
    RENEE, N
    THYSS, A
    SCHNEIDER, M
    DEMARD, F
    BRITISH JOURNAL OF CANCER, 1992, 66 (04) : 668 - 672
  • [46] A role for levamisole (LEV) in the adjuvant treatment of stage III colon cancer: A randomized trial of 5-fluorouracil (5FU) and LEV vs 5FU alone
    Catalano, V
    Cascinu, S
    Latini, L
    Mattioli, R
    Marcellini, M
    Pancotti, A
    Bascioni, R
    Torresi, U
    Silva, RR
    Pieroni, V
    Giorgi, F
    Testa, I
    Sturba, F
    Ferretti, B
    Catalano, G
    Cellerino, R
    ANNALS OF ONCOLOGY, 2000, 11 : 66 - 66
  • [47] Adjuvant therapy (AT) with raltitrexed (RAL) in colorectal cancer (CRC) patients (pts) intolerant of 5-fluorouracil (5FU).
    Wilson, K. S.
    Barnett, J. B.
    Gill, S.
    Khoo, K. E.
    Fitzgerald, C. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 163S - 163S
  • [48] Prognostic factors influencing the survival of patients with colon cancer receiving adjuvant 5-FU treatment
    Kornmann, M.
    Formentini, A.
    Ette, C.
    Henne-Bruns, D.
    Kron, M.
    Sander, S.
    Baumann, W.
    Kreuser, E. -D.
    Staib, L.
    Link, K. H.
    EJSO, 2008, 34 (12): : 1316 - 1321
  • [49] Adjuvant radiotherapy for high-risk patients following radical prostatectorny
    Swanson, Gregory P.
    Thompson, Ian M.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2007, 25 (06) : 515 - 519
  • [50] 5-DRUG ADJUVANT CHEMOTHERAPY IN HIGH-RISK PATIENTS WITH BREAST-CANCER
    CAREY, RW
    KAUFMAN, S
    SOHIER, WD
    KELLEY, RM
    LEW, R
    HALPERN, E
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 404 - 404
12345